Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
US Army
Covington
Dow
Fish and Richardson
AstraZeneca
Argus Health
Cipla
Boehringer Ingelheim

Generated: February 19, 2018

DrugPatentWatch Database Preview

EMBELINE Drug Profile

« Back to Dashboard

When do Embeline patents expire, and when can generic versions of Embeline launch?

Embeline is a drug marketed by Hi Tech Pharma and is included in four NDAs.

The generic ingredient in EMBELINE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Drug patent expirations by year for EMBELINE
Pharmacology for EMBELINE
Medical Subject Heading (MeSH) Categories for EMBELINE

US Patents and Regulatory Information for EMBELINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hi Tech Pharma EMBELINE clobetasol propionate GEL;TOPICAL 076141-001 Apr 12, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma EMBELINE E clobetasol propionate CREAM;TOPICAL 075325-001 Dec 24, 1998 AB2 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma EMBELINE clobetasol propionate OINTMENT;TOPICAL 074221-001 Mar 31, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma EMBELINE clobetasol propionate SOLUTION;TOPICAL 074222-001 Dec 6, 1995 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Argus Health
Accenture
Healthtrust
Federal Trade Commission
Cerilliant
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot